Northern Star Resources Ltd (NESRF) Receives a Hold from UBS
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks, Spry is a 5-star analyst with an average return of 12.1% and a 66.36% success rate. Spry covers the Basic Materials sector, focusing on stocks such as Northern Star Resources Ltd, Evolution Mining , and Perseus Mining .
Northern Star Resources Ltd has an analyst consensus of Moderate Buy, with a price target consensus of $14.00, implying a 27.27% upside from current levels. In a report released on July 7, RBC Capital also maintained a Hold rating on the stock with a A$19.00 price target.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
UBS Lifts PT on QUALCOMM Incorporated (QCOM) to $165 From $145, Keeps a Neutral Rating
QUALCOMM Incorporated (NASDAQ:QCOM) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, UBS raised the firm's price target on QUALCOMM Incorporated (NASDAQ:QCOM) to $165 from $145, keeping a Neutral rating on the shares. A technician testing the latest 5G device, demonstrating the company's commitment to innovation. The firm told investors in a research note that it expects a modest upside bias to the company's Q3 results in a backdrop showing solid signs of tariff-related pull-ins for Android and Apple units in the quarter. However, it also added that it does not expect this momentum to be sustained into the second half of the year as pull-ins usually wane, primarily because the end consumption for smartphones and PC has failed to get any better. QUALCOMM Incorporated (NASDAQ:QCOM) develops and commercializes foundational technologies for the wireless industry, including 3G, 4G, and 5G wireless connectivity and high-performance and low-power computing, including on-device AI. While we acknowledge the potential of QCOM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Business Insider
30 minutes ago
- Business Insider
IBM and Cleveland Clinic Build an AI Model that Predicts Brain Disorders
The way people walk, their gait, can reveal early signs of serious neurological conditions such as Parkinson's disease, cerebral palsy, dementia, and cognitive decline. Subtle differences in stride, balance, and timing often give clues about these conditions, but traditional gait assessments rely heavily on visual observation by doctors. This approach can be subjective, time‑consuming, and limited to controlled environments. However, a new collaboration between tech giant IBM (IBM) and Cleveland Clinic hopes to change this by creating an AI system that can work with many types of neurological conditions and sensor setups, including everyday devices like smartphone cameras and wearables. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. At the center of this work is an AI foundation model called GaitFM, trained on a mix of real and synthetic data. Most of the training data comes from physics‑based simulations of walking that mimic the effects of age, disease, and different types of sensors. This synthetic data helps solve a major problem in gait research: there is very little gait data available online. By first training on synthetic data and then fine‑tuning with smaller clinical datasets, GaitFM can recognize the gait patterns of different diseases. Early tests show that GaitFM can estimate key movement features, classify conditions, and even predict disease progression. In studies, models trained on synthetic data alone were able to perform competitively, and combining synthetic with real data provided the best results. The technology is already being piloted at Cleveland Clinic and recently won Best Paper at the 2025 IEEE International Conference on Digital Health. Researchers believe this approach could make gait analysis widely accessible and scalable, especially for rare conditions where collecting real data is difficult. Is IBM a Buy, Sell, or Hold? Turning to Wall Street, analysts have a Moderate Buy consensus rating on IBM stock based on seven Buys, four Holds, and one Sell assigned in the past three months, as indicated by the graphic below. Furthermore, the average IBM price target of $297.33 per share implies 14.5% upside potential.
Business Insider
30 minutes ago
- Business Insider
BTIG Sticks to Their Buy Rating for Steven Madden (SHOO)
BTIG analyst Janine Stichter maintained a Buy rating on Steven Madden today and set a price target of $34.00. The company's shares closed today at $23.87. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Stichter covers the Consumer Cyclical sector, focusing on stocks such as Boot Barn, Steven Madden, and Deckers Outdoor. According to TipRanks, Stichter has an average return of 6.2% and a 43.75% success rate on recommended stocks. In addition to BTIG, Steven Madden also received a Buy from TR | OpenAI – 4o's Jax Loafter in a report issued on July 18. However, today, Needham maintained a Hold rating on Steven Madden (NASDAQ: SHOO). Based on Steven Madden's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $553.53 million and a net profit of $40.42 million. In comparison, last year the company earned a revenue of $552.38 million and had a net profit of $43.93 million Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SHOO in relation to earlier this year. Most recently, in May 2025, Al Ferrara, a Director at SHOO bought 4,000.00 shares for a total of $104,200.00.
